ADELE SOINS INFIRMIERS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ADELE SOINS INFIRMIERS
Largest movements
- Cash -€16,845
down €16,845 (-36.4%), from €46,261 to €29,415
mainly Contributions, distributions and other (-€56,629) and Tax, wage and social debts (-€1,067)
- Tangible fixed assets -€5,000
down €5,000 (-54.0%), from €9,260 to €4,260
- Deferred charges and accrued income -€2,071
down €2,071 (-22.7%), from €9,118 to €7,047
- Profit (loss) carried forward -€32,128
down €32,128 (-100%), from €32,128 to €0
- Other debts +€13,484
up €13,484 (+78.6%), from €17,164 to €30,648
- Reserves -€4,206
down €4,206 (-100%), from €4,206 to €0
- Tax, wage and social debts -€1,067
down €1,067 (-13.1%), from €8,126 to €7,059
- Gross operating margin +€2,194
up €2,194 (+7.2%), from €30,621 to €32,815
- Taxes +€512
up €512 (+8.3%), from €6,169 to €6,682
- Other operating charges +€437
up €437 (+181%), from €241 to €678
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €64,639 | €40,723 | -€23,917 | -37.0% |
| Fixed assets | 21/28 | €9,260 | €4,260 | -€5,000 | -54.0% |
| Tangible fixed assets | 22/27 | €9,260 | €4,260 | -€5,000 | -54.0% |
| Furniture and vehicles | 24 | €9,260 | €4,260 | -€5,000 | -54.0% |
| Current assets | 29/58 | €55,379 | €36,462 | -€18,917 | -34.2% |
| Amounts receivable within one year | 40/41 | €0 | - | = | |
| Trade receivables | 40 | €0 | - | = | |
| Cash at bank and in hand | 54/58 | €46,261 | €29,415 | -€16,845 | -36.4% |
| Deferred charges and accrued income | 490/1 | €9,118 | €7,047 | -€2,071 | -22.7% |
| Total equity and liabilities | 10/49 | €64,639 | €40,723 | -€23,917 | -37.0% |
| Equity | 10/15 | €39,335 | €3,000 | -€36,335 | -92.4% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Reserves | 13 | €4,206 | €0 | -€4,206 | -100% |
| Distributable reserves | 133 | €4,206 | €0 | -€4,206 | -100% |
| Profit (loss) carried forward | 14 | €32,128 | €0 | -€32,128 | -100% |
| Amounts payable | 17/49 | €25,305 | €37,723 | +€12,418 | +49.1% |
| Amounts payable within one year | 42/48 | €25,290 | €37,707 | +€12,417 | +49.1% |
| Taxes, remuneration and social security | 45 | €8,126 | €7,059 | -€1,067 | -13.1% |
| Taxes | 450/3 | €8,126 | €7,059 | -€1,067 | -13.1% |
| Other amounts payable | 47/48 | €17,164 | €30,648 | +€13,484 | +78.6% |
| Accrued charges and deferred income | 492/3 | €15 | €15 | +€0 | +3.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €5,000 | €5,000 | = | 0.0% |
| Other operating charges | 640/8 | €241 | €678 | +€437 | +181% |
| Gross operating margin | 9900 | €30,621 | €32,815 | +€2,194 | +7.2% |
| Operating profit (loss) | 9901 | €25,380 | €27,137 | +€1,757 | +6.9% |
| Financial income | 75/76B | €0 | - | = | |
| Recurring financial income | 75 | €0 | - | = | |
| Financial charges | 65/66B | €181 | €160 | -€20 | -11.1% |
| Recurring financial charges | 65 | €181 | €160 | -€20 | -11.1% |
| Profit (loss) for the period before taxes | 9903 | €25,199 | €26,976 | +€1,777 | +7.1% |
| Income taxes | 67/77 | €6,169 | €6,682 | +€512 | +8.3% |
| Profit (loss) for the period | 9904 | €19,030 | €20,295 | +€1,265 | +6.6% |
| Profit (loss) for the period to be appropriated | 9905 | €19,030 | €20,295 | +€1,265 | +6.6% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.